GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Apollomics Inc (NAS:APLMW) » Definitions » Other Long Term Assets

Apollomics (Apollomics) Other Long Term Assets : $0.12 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Apollomics Other Long Term Assets?

Apollomics's other long-term assets for the quarter that ended in Dec. 2023 was $0.12 Mil.

Apollomics's quarterly other long-term assets declined from Dec. 2022 ($0.12 Mil) to Jun. 2023 ($0.12 Mil) but then increased from Jun. 2023 ($0.12 Mil) to Dec. 2023 ($0.12 Mil).

Apollomics's annual other long-term assets increased from Dec. 2021 ($0.11 Mil) to Dec. 2022 ($0.12 Mil) but then declined from Dec. 2022 ($0.12 Mil) to Dec. 2023 ($0.12 Mil).


Apollomics Other Long Term Assets Historical Data

The historical data trend for Apollomics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollomics Other Long Term Assets Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
0.09 0.11 0.12 0.12

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Long Term Assets Get a 7-Day Free Trial 0.11 0.13 0.12 0.12 0.12

Apollomics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Apollomics (Apollomics) Business Description

Traded in Other Exchanges
Address
989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Apollomics Inc is an innovative clinical-stage biotechnology company. It is is focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. It has a pipeline of 9 drug candidates across multiple programs, 6 of which are in the clinical stage of development.